Vanda Pharmaceuticals Newsroom

H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 8 07:35 ET

Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 7 08:31 ET

Vanda Pharma Analyst Ratings

BenzingaOct 31 08:05 ET

H.C. Wainwright Initiates Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $18

Moomoo NewsOct 31 06:31 ET

Vanda Pharma Analyst Ratings

BenzingaAug 1 12:55 ET

Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Raises Target Price to $13

Moomoo NewsAug 1 08:31 ET

Vanda Pharma Analyst Ratings

BenzingaJul 11 07:28 ET